HARVEY HSIANG M.D.
NPI 1528001542
Internal Medicine - Medical Oncology in Ft Walton Beach, FL
Quality Rating: 100 out of 100 score
NPI Status: Active since June 14, 2006
Contact Information
1024 MAR WALT DR
FT WALTON BEACH, FL
ZIP 32547
Phone: (850) 863-3148
- Individual
- Male
- Internal Medicine
- Medical Oncology
- Medicare Quality Reporting
About HARVEY HSIANG
This page provides the complete NPI Profile along with additional information for Harvey Hsiang, an internist established in Ft Walton Beach, Florida with a medical specialization in Internal Medicine, focusing in medical oncology . The healthcare provider is registered in the NPI registry with number 1528001542 assigned on June 2006. The practitioner's primary taxonomy code is 207RX0202X with license number ME0065929 (FL). The provider is registered as an individual and his NPI record was last updated 14 years ago.
- NPI
- 1528001542
- Provider Name
- HARVEY HSIANG M.D.
- Gender
- Male
- Entity Type
- Individual
- Location Address
- 1024 MAR WALT DR FT WALTON BEACH, FL 32547
- Location Phone
- (850) 863-3148
- Mailing Address
- 1024 MAR WALT DR FT WALTON BEACH, FL 32547
- Mailing Phone
- (850) 863-3148
- Is Sole Proprietor?
- No
- Enumeration Date
- 06-14-2006
- Last Update Date
- 02-09-2012
- Code Navigator
An internist like Harvey Hsiang is a physician who has completed an internal medicine residency and is board-certified or board-eligible in an internist specialty. Internists are trained to care for adults of all ages for many different medical conditions. An internist typically monitors chronic physical conditions, identifies acute diseases, provides family planning, provides counseling about wellness and disease prevention, etc.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Internal Medicine Medical Oncology
- Taxonomy Code
- 207RX0202X
- Type
- Allopathic & Osteopathic Physicians
- License No.
- ME0065929
- License State
- FL
- Taxonomy Description
- An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.
Insurance Plans Accepted
According to publicly available information the provider might be accepting the following health plans from these health insurance companies:
Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.
Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.
*Please verify directly with this provider to make sure your insurance plan is currently accepted.
Additional Identifiers
The NPI Enumerator encourages providers to submit additional identifiers with their NPI application although the submission of this information is optional. The additional identifier(s) section includes other numbers or codes currently or formerly used as an identifier for the provider by other public healthcare entities. The identifiers may include UPIN, NSC, OSCAR, DEA, Medicaid State or PIN identification numbers.
| Identifier | Type / Code | Identifier State | Identifier Issuer |
|---|---|---|---|
| 28636 | MEDICARE ID-TYPE UNSPECIFIED (04) | FL | |
| G04800 | MEDICARE UPIN (02) | FL |
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
Administration of additional new drug or substance into vein using push technique
Administration of additional new drug or substance into vein, 1 hour or less
Administration of chemotherapy into vein, 1 hour or less
Administration of chemotherapy into vein, each additional hour
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
Drawing of blood for a medical problem
Established patient office or other outpatient visit, 20-29 minutes
Established patient office or other outpatient visit, 30-39 minutes
Established patient office or other outpatient visit, 40-54 minutes
Follow-up hospital inpatient care per day, typically 25 minutes
Infusion into a vein for hydration, 31-60 minutes
Infusion into a vein for hydration, each additional hour
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
Infusion, normal saline solution, sterile (500 ml = 1 unit)
Initial hospital inpatient care per day, typically 70 minutes
Injection of additional new drug or substance into vein
Injection of drug or substance under skin or into muscle
Injection, bortezomib (velcade), 0.1 mg
Injection, carboplatin, 50 mg
Injection, denosumab, 1 mg
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, epoetin alfa, (for non-esrd use), 1000 units
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
Injection, ferric carboxymaltose, 1 mg
Injection, ferric derisomaltose, 10 mg
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
Injection, granisetron hydrochloride, 100 mcg
Injection, nivolumab, 1 mg
Injection, paclitaxel, 1 mg
Injection, palonosetron hcl, 25 mcg
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
Injection, pembrolizumab, 1 mg
Injection, rituximab, 10 mg
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
Insertion of needle into vein for collection of blood sample
Irrigation of implanted venous access drug delivery device
Leuprolide acetate (for depot suspension), 7.5 mg
New patient office or other outpatient visit, 60-74 minutes
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
This procedure involves injecting a new medication or substance directly into your vein using a method called the 'push' technique. It's a quick way to deliver medication into your bloodstream for fast-acting relief or treatment.
This service was performed 59 times for 17 patientsThis procedure involves introducing a new drug or substance into your vein, typically via an IV drip. It lasts for an hour or less. This method allows the substance to quickly reach your bloodstream, ensuring rapid and effective treatment.
This service was performed 256 times for 41 patientsChemotherapy is a treatment that uses drugs to destroy cancer cells. When administered into a vein, it's often through an IV. This procedure usually lasts 1 hour or less. You may feel a slight pinch as the needle is inserted, but it's generally painless.
This service was performed 793 times for 142 patientsChemotherapy is a treatment method that uses drugs to destroy cancer cells. The drugs are administered into a vein, usually in the arm. Each additional hour of chemotherapy allows for more of the medication to enter your bloodstream to fight against the cancer cells.
This service was performed 242 times for 47 patientsThis procedure involves the injection of hormone-based anti-cancer drugs under the skin or into a muscle. These medications help to slow down or stop the growth of certain types of cancer cells. The process is usually quick and can be performed in a clinic or hospital.
This service was performed 112 times for 36 patientsThis procedure involves giving anti-cancer drugs, which don't contain hormones, into the muscle or under the skin. These drugs help to stop the growth of cancer cells. The process is usually quick and done by a healthcare professional.
This service was performed 383 times for 61 patientsA Complete Blood Cell Count is a common test that measures various components of the blood, including red cells (carry oxygen), white cells (fight infection), and platelets (help blood clot). An automated test ensures accuracy. The differential count provides detailed information about white cell types.
This service was performed 3,040 times for 779 patientsDrawing blood is a simple procedure where a needle is inserted into a vein, usually in your arm, to collect a small sample. This sample helps in diagnosing any medical issues you may have. You might feel a small prick, but overall, it's a quick and safe process.
This service was performed 42 times for 19 patientsThis is a routine visit for patients who have already been seen by the healthcare provider. During this approximately 20-29 minute appointment, your health status will be evaluated and any necessary treatments or tests will be discussed. It's a chance to address any health concerns you may have.
This service was performed 1,967 times for 848 patientsThis is a routine check-up for patients who have previously visited our clinic. It involves a comprehensive review of your health and any ongoing treatments. The consultation lasts between 30-39 minutes, allowing enough time to discuss any concerns.
This service was performed 216 times for 153 patientsThis service involves a follow-up appointment for existing patients, lasting between 40 to 54 minutes. During this time, your healthcare provider will assess your current health status, discuss any changes or concerns, review your treatment plan, and answer any questions you may have.
This service was performed 17 times for 17 patientsFollow-up hospital inpatient care involves daily check-ups while you're admitted in the hospital. Typically, a healthcare provider spends about 25 minutes each day reviewing your condition, adjusting treatment if needed, and answering any questions you might have.
This service was performed 139 times for 51 patientsThis is a procedure where a sterile solution is administered into your vein to help restore body fluid balance. It typically lasts between 31-60 minutes. It's a safe, common treatment for dehydration or to deliver medication.
This service was performed 32 times for 14 patientsThis procedure involves delivering fluids directly into your vein to keep your body hydrated. It is typically done when oral hydration is insufficient. Each additional hour means more fluid is infused to ensure adequate hydration.
This service was performed 54 times for 14 patientsAn infusion into a vein is a method of delivering medication, nutrients, or fluids directly into your bloodstream. If it's concurrent with another infusion, it means two different solutions are given at the same time. This can be for treatment, prevention, or diagnostic purposes.
This service was performed 76 times for 18 patientsThis is a procedure where a medical professional inserts a small tube into your vein to deliver medication, nutrients, or fluids directly into your bloodstream. This can be for treatment, prevention, or diagnosis. The process typically takes less than an hour.
This service was performed 164 times for 89 patientsThis procedure involves injecting fluids or medication directly into your vein. It's used for treatment, prevention, or diagnosis. An additional sequential infusion may be given within an hour if needed. This helps to ensure the medicine is distributed effectively in your body.
This service was performed 645 times for 76 patientsThis procedure involves delivering medication, fluids, or nutrients directly into your vein. This is done to treat, prevent, or diagnose various conditions. Each additional hour refers to the extended time you may need to receive these substances for optimal results.
This service was performed 49 times for 15 patientsAn infusion of a normal saline solution is a common medical procedure. Sterile saline (salt water) is administered into your bloodstream via a drip. This helps to maintain fluid balance in your body, especially when you're unable to drink enough liquids.
This service was performed 63 times for 19 patientsInitial hospital inpatient care per day, typically 70 minutes, refers to the daily medical service provided to patients admitted to the hospital. This includes a comprehensive evaluation, diagnosis, treatment plan, and monitoring of your health condition. It ensures your well-being during your hospital stay.
This service was performed 69 times for 65 patientsThis procedure involves introducing a new medication or substance into your bloodstream via a vein. It's typically done using a small needle. The substance can help treat various conditions or assist in diagnostic procedures. It's generally safe and monitored by professionals.
This service was performed 450 times for 81 patientsThis procedure involves administering medication directly under the skin or into a muscle. A small needle is used to inject the drug, allowing it to be absorbed quickly into the bloodstream. It's a common method for delivering a variety of medications.
This service was performed 759 times for 193 patientsBortezomib (Velcade) is a medication administered through an injection. It's used to treat multiple myeloma and mantle cell lymphoma, types of cancer. It works by blocking certain proteins in cancer cells, slowing their growth.
This service was performed 4,025 times for 11 patientsCarboplatin is a chemotherapy drug used to treat various types of cancer by slowing or stopping the growth of cancer cells. The 50 mg injection is administered into a vein by a healthcare professional. Side effects may occur.
This service was performed 478 times for 24 patientsDenosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
This service was performed 16,980 times for 117 patientsDexamethasone sodium phosphate is a medication given via injection. It is a type of steroid that helps reduce inflammation and immune responses. It can be used to treat a variety of conditions, such as allergies, skin conditions, arthritis, and more.
This service was performed 5,710 times for 71 patientsDiphenhydramine HCL injection is a medicine given to alleviate symptoms of allergies, colds, or hay fever. It can also help with motion sickness and certain symptoms of Parkinson's disease. Up to 50 mg may be administered depending on your condition.
This service was performed 42 times for 14 patientsEpoetin alfa is a medication injected to help your body produce more red blood cells, improving energy levels and reducing tiredness. It's often used for patients with certain types of anemia. Each injection contains 1000 units of the medicine.
This service was performed 6,260 times for 31 patientsEpoetin alfa-epbx (Retacrit) is a biosimilar injection used for non-ESRD (End-Stage Renal Disease). It helps your body make more red blood cells, increasing your energy and well-being. It's usually given under the skin or into a vein by a healthcare professional.
This service was performed 8,500 times for 52 patientsFerric carboxymaltose is an iron supplement injection. It's given when your body needs more iron than you can consume through diet, like in anemia. The injection is administered by a healthcare professional into a vein.
This service was performed 48,750 times for 38 patientsFerric derisomaltose is an iron replacement product. It's given as an injection to treat iron deficiency anemia, a condition where the body lacks enough iron. The injection helps increase iron in your body to healthy levels.
This service was performed 2,700 times for 23 patientsFerumoxytol injection is a treatment for iron deficiency anemia, a condition where your body lacks enough iron. It is injected into your vein to increase iron levels, aiding in the production of healthy red blood cells. This treatment is not for ESRD patients.
This service was performed 11,220 times for 12 patientsFilgrastim-sndz, also known as Zarxio, is a biosimilar medicine administered via injection. It's designed to stimulate the growth of white blood cells, which play a crucial role in your body's defense against infections. This can be particularly beneficial if your white blood cell count is low due to certain treatments or conditions.
This service was performed 76,320 times for 26 patientsGranisetron hydrochloride is an anti-nausea medication given by injection. It helps prevent nausea and vomiting often caused by cancer treatments like chemotherapy. Its dosage is measured in micrograms (mcg).
This service was performed 930 times for 16 patientsNivolumab is a medication given via injection, often used in cancer treatment. It works by helping your immune system fight the cancer cells. The dosage is measured in milligrams (mg), with 1 mg being a common dose.
This service was performed 28,692 times for 16 patientsPaclitaxel is a medication administered via injection to treat various types of cancer. It works by inhibiting cell division, thus preventing cancer cells from growing and multiplying. Each dose is tailored to the patient's body size.
This service was performed 4,570 times for 15 patientsPalonosetron HCL is an injection used to prevent nausea and vomiting caused by chemotherapy. It works by blocking a natural substance (serotonin) in the body that can cause vomiting. This helps improve your comfort during cancer treatment.
This service was performed 3,607 times for 69 patientsPegfilgrastim is a medication given via injection to stimulate the production of white blood cells. It's used to prevent infections after chemotherapy. This specific dose is 0.5 mg, and it's not a biosimilar, meaning it's the original, not a copy.
This service was performed 204 times for 12 patientsPembrolizumab is a medication given via injection to help your body's immune system fight certain types of cancer. It's typically administered in a hospital or clinic by a healthcare professional.
This service was performed 31,767 times for 31 patientsRituximab is a medication given via injection. It's used to treat certain types of cancer and autoimmune diseases. The 10 mg dosage refers to the amount of the drug in the injection. It works by targeting and destroying specific cells, helping your body's immune system.
This service was performed 3,570 times for 19 patientsThis is a procedure where a small dose of Vitamin B-12, also known as Cyanocobalamin, is injected into your body. This vitamin is essential for nerve function and the production of red blood cells. It's often used to treat vitamin B-12 deficiency.
This service was performed 52 times for 16 patientsThis procedure involves inserting a small needle into a vein, typically in your arm, to collect a blood sample. It's a quick and simple process to help diagnose or monitor health conditions. You may feel a small prick, but discomfort is minimal.
This service was performed 1,719 times for 703 patientsIrrigation of an implanted venous access drug delivery device is a procedure to clean or unblock the device. This device is implanted under your skin to allow easy, frequent, and long-term access to your veins for medication delivery. The process involves flushing the device with a sterile solution to ensure it works properly.
This service was performed 66 times for 34 patientsLeuprolide acetate is a medication that helps regulate certain hormone levels in your body. It's injected into your muscle once a month. This treatment can help manage various health conditions related to hormone imbalance. Always follow your doctor's instructions.
This service was performed 142 times for 27 patientsThis is a first-time patient visit where a healthcare professional spends 60-74 minutes with you. It involves a comprehensive evaluation, including your medical history and current health condition. They'll also advise on preventive health measures and formulate a treatment plan if needed.
This service was performed 140 times for 140 patientsThis service involves an outpatient visit for established patients who may not need direct interaction with a healthcare professional. It could include reviewing test results, monitoring existing conditions, or adjusting treatment plans. It's typically done remotely, ensuring your comfort and convenience.
This service was performed 939 times for 292 patientsThe Oncology Care Model (OCM) Monthly Enhanced Oncology Services (MEOS) payment, denoted by G9678, is a compensation method for OCM practitioners. These payments are specifically for providing additional, or "enhanced", services to OCM beneficiaries, as outlined in the OCM participation agreement.
This service was performed 107 times for 60 patientsOverall MIPS Quality Performance
The provider participated in CMS Quality Payment Program under the Merit-based Incentive Payment System (MIPS) and has an overall final score of 100, based on four performance areas: quality, improvement activities, promoting interoperability, and cost. The purpose of this information is to help people with Medicare make informed decisions and incentivize doctors and clinicians to maximize performance.
The Merit-based Incentive Payment System (MIPS) is a way providers could use to participate in CMS Quality Payment Program (QPP). The MIPS program affects clinician reimbursement for Part B covered professional services and also rewards them for improving the quality of patient care and outcomes.
-
Final Score: 100 out of 100
The MIPS program evaluates providers across multiple categories with a specific weight for each category resulting a in a MIPS final score that ranges from 0 to 100 points. The MIPS Final Score determines whether providers receive a negative, neutral or positive MIPS payment adjustment.
-
Quality Score: 95.75
The Quality category assesses providers performance on clinical practices and patient outcomes under the traditional MIPS program. The quality measures help identify the quality of healthcare processes, outcomes, and patient experiences. The Quality measure category comprises 40% of a provider's final MIPS score.
There are six collection types for MIPS quality measures: Electronic Clinical Quality Measures (eCQMs), MIPS Clinical Quality Measures (CQMs), Qualified Clinical Data Registry (QCDR) Measures, Medicare Part B claims measures, CMS Web Interface measures and The Consumer Assessment of Healthcare Providers and Systems (CAHPS) for MIPS Survey.
-
Promoting Interoperability Score: N/A
The Interoperability category measures the providers ability to use technology to exchange and make use of healthcare information in a way that is less burdensome and improves outcomes. The Interoperability measure category comprises 25% of a provider's final MIPS score.
The MIPS Interoperability measure focuses on the use of certified electronic health record technology (CEHRT) to improve patient access health information, the exchange of information between clinicians and pharmacies and the systematic collection, analysis, and interpretation of healthcare data. -
Improvement Activities Score: 40
The Improvement Activities performance category evaluates the providers participation in clinical activities that support the improvement of clinical practice, care delivery, and outcomes. Providers have the option to choose 2 to 4 activities from an inventory of over 100 improvement activities. Providers typically choose the activities that best fit their needs. The improvement activities measure category comprises 15% of a provider's final MIPS score.
The Improvement measures aim to better patient engagement, patient safety and other areas of patient care. The Improvement Activities category comprises 15% of a provider's final MIPS score. -
Cost Score: N/A
The Cost performance category assesses the amount and types of services provided and how clinicians coordinate care and seek improvement of health outcomes by ensuring patients receive the appropriate services.
Although providers don't determine the price of healthcare services they are important in delivering high-quality care at a reasonable cost. The Cost measures category comprises 20% of a provider's final MIPS score.
Quality Reporting
The provider participated in CMS Quality Payment Program. The Quality Payment Program aims to improve population health, reduce costs and improve the care received by Medicare beneficiaries. The following quality measures meet Medicare's statistical reporting standards. Not all providers report the same information, because not all providers give the same services to patients. The quality information is just a snapshot of some the care providers give to their patients. Reporting more or less information is not a reflection of quality.
| Quality Measure | Performance | Number of Patients |
|---|---|---|
| Advance Care Planning | Yes | N/A |
| Implementation of practices/processes to develop advance care planning that includes: documenting the advance care plan or living will within the medical record, educating clinicians about advance care planning motivating them to address advance care planning needs of their patients, and how these needs can translate into quality improvement, educating clinicians on approaches and barriers to talking to patients about end-of-life and palliative care needs and ways to manage its documentation, as well as informing clinicians of the healthcare policy side of advance care planning. | ||
| Annual registration in the Prescription Drug Monitoring Program | Yes | N/A |
| Annual registration by eligible clinician or group in the prescription drug monitoring program of the state where they practice. Activities that simply involve registration are not sufficient. MIPS eligible clinicians and groups must participate for a minimum of 6 months. | ||
| Care Plan | 98% | 1230 |
| Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record that an advance care plan was discussed but the patient did not wish or was not able to name a surrogate decision maker or provide an advance care plan | ||
| Colorectal Cancer Screening | 51% | 1076 |
| Percentage of adults 50-75 years of age who had appropriate screening for colorectal cancer | ||
| Documentation of Current Medications in the Medical Record | 85% | 5987 |
| Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. This list must include ALL known prescriptions, over-the-counters, herbals, and vitamin/mineral/dietary (nutritional) supplements AND must contain the medications' name, dosage, frequency and route of administration | ||
| Health Information Exchange | 63% | 72 |
| The MIPS eligible clinician that transitions or refers their patient to another setting of care or health care clinician (1) uses CEHRT to create a summary of care record; and (2) electronically transmits such summary to a receiving health care clinician for at least one transition of care or referral. | ||
| Medication Reconciliation | 95% | 364 |
| The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician. | ||
| Oncology: Medical and Radiation - Pain Intensity Quantified | 99% | 2810 |
| Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified | ||
| Oncology: Medical and Radiation - Plan of Care for Pain | 98% | 1401 |
| Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain | ||
| Pain Assessment and Follow-Up | 94% | 5987 |
| Percentage of visits for patients aged 18 years and older with documentation of a pain assessment using a standardized tool(s) on each visit AND documentation of a follow-up plan when pain is present | ||
| Patient-Specific Education | 96% | 1934 |
| The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician. | ||
| Pneumococcal Vaccination Status for Older Adults | 77% | 1238 |
| Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine | ||
| Preventive Care and Screening: Influenza Immunization | 6% | 1748 |
| Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization | ||
| Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 93% | 122 |
| Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user | ||
| Provide Patient Access | 100% | 1934 |
| At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold certain information. | ||
| Secure Messaging | 96% | 1934 |
| For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure message sent by the patient (or the patient-authorized representative) during the performance period. | ||
| Security Risk Analysis | Yes | N/A |
| Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.308(a)(1), including addressing the security (to include encryption) of ePHI data created or maintained by certified EHR technology in accordance with requirements in 45 CFR164.312(a)(2)(iv) and 45 CFR 164.306(d)(3), and implement security updates as necessary and correct identified security deficiencies as part of the MIPS eligible clinician's risk management process. | ||
| Specialized Registry Reporting | Yes | N/A |
| The MIPS eligible clinician is in active engagement to submit data to specialized registry. To earn a 5 % bonus in the promoting interoperability performance category score for submitting to one or more public health or clinical data registries also attest to PI_TRANS_PHCDRR_3_MULTI. | ||
| Syndromic Surveillance Reporting | Yes | N/A |
| The MIPS eligible clinician is in active engagement with a public health agency to submit syndromic surveillance data. To earn a 5 % bonus in the promoting interoperability performance category score for submitting to one or more public health or clinical data registries also attest to PI_TRANS_PHCDRR_2_MULTI. | ||
Reviews for HARVEY HSIANG M.D.
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1528001542, we treat the final digit (2) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 58. The final step is to find the difference between that total and the next multiple of ten (60 - 58 = 2).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 58 is 60. The difference is the calculated check digit.
Other Providers at the Same Location
The following 7 providers are registered at the same or a nearby location.
FT WALTON BEACH, FL 32547
FORT WALTON BEACH, FL 32547
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1528001542, enumerated as an "individual" on June 14, 2006.
The provider is located at 1024 MAR WALT DR FT WALTON BEACH, FL 32547 and the phone number is (850) 863-3148.
Internal Medicine with taxonomy code 207RX0202X and a focus in Medical Oncology.
The provider might be accepting Accepts: Medicare and Medicaid. Please consult your insurance carrier or call the provider to verify.